Patent · US Active

Pharmaceutically active pyrazolo-triazine derivatives

US9096608B2 · kind B2 · utility

5Cited by

0References

5Claims

0Family size

Assignee

Lead Discovery Center GmbH · DE

Inventors

Jan Eickhoff · Herdecke, DE
Gunther Zischinsky · Berlin, DE
Uwe Koch · Roma, IT
Gerd Ruhter · Hamburg, DE
Carsten Schultz-Fademrecht · Pomezia, IT
Peter Nussbaumer · Schwanenstadt, AT

Key dates

Filing date	Mar 1, 2013
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Mar 1, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyrazolo[1,5-a][1,3,5]triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said pyrazolo[1,5-a][1,3,5]triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors for a protein kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.